Emifenac ®
Analgesic, Anti-inflammatory
Composition:
Emifenac 50 DT: Each Emifenac 50 DT dispersible tablet contains diclofenac 46.5mg equivalent to diclofenac sodium 50mg.
Diclofenac free acid
{2-[(2,6-dichlorophenyl)-a
Emifenac 50 DT Dispersible Tablets, specifically to disintegrate quickly in water, yielding a tasteless suspension of diclofenac free acid.
The suspension is to be taken orally.
Emifenac 100 SRT: Each Emifenac 100 SRT sustained release tablet contains diclofenac sodium 100 mg.
Indications:
Emifenac is indicated in the following conditions:
Ø Post-operative pain, inflammation, and swelling e.g. following dental or orthopedic surgery.
Ø Painful post-traumatic inflammatory states, e.g. due to sprains.
Ø Non-articular rheumatism
Ø Painful symptoms of the vertebral column.
Ø Painful and/or inflammatory conditions in gynaecology, e.g. primary dysmenorrhoea
Ø Acute attacks of gout.
Ø As an adjuvant in severe painful inflammatory infections of the ear, nose, or throat, e.g. pharyngitis, otitis. In keeping with general therapeutic principles, the underlying disease should be treated with basic therapy, as appropriate. Fever alone is not an indication.
Contraindications:
Emifenac like other non-steroidal anti-inflammatory drugs, should not be given to patients with active peptic ulcer and to patients in whom attacks of asthma, angioedema, urticaria or acute rhinitis have been precipitated by aspirin or any other drugs with prostaglandin-synthetase inhibiting activity. Emifenac should be avoided in patients with a history of acute prophyria.
Emifenac 50 DT contains phenylalanine and should not be given to phenylketonurics patients.
Dosage and Administration:
Emifenac 50 DT: Emifenac 50 DT dispersible tablets should preferably be taken before meals.
Emifenac 50 DT dispersible tablets are dropped into a glass of water and stirred to aid dispersion before swallowing. Since a portion of the active substance (diclofenac) may remain in the glass after swallowing, it is advisable to rinse the glass with a small of water and to swallow again.
Adults: The recommended initial dosage is 2-3 Emifenac 50 DT dispersible tablets.
In milder cases as well as for children over 14 years of age, 2 Emifenac 50 DT dispersible tablets daily are usually sufficient.
The daily dosage should generally be prescribed in 2-3 divided doses.
In primary dysmenorrhea the daily dosage, which should be individually adapted, is generally 1-3 Emifenac 50 DT.
Children: Because of the dosage strength, Emifenac50 DT Dispersible tablets are not recommended for use in children below 14 years of age.
Emifenac 100 SRT:
Adults: The recommended initial dosage is 1 tablet of Emifenac 100 SRT sustained release tablets.
In milder cases as well as for long-term therapy, 1 tablet of Emifenac 100 SRT is usually sufficient. Where the symptoms are most pronounced during the night or in the morning should preferably be taken in the evening. The tablets should be taken whole with liquid, preferably with meals.
Children: Because of the dosage strength, Emifenac 100 SRT sustained release tablets are not recommended for use in children below 14 years of age.
Presentation:
Emifenac 50 DT dispersible tablets are available in packs of 20 and 100 tablets.
Emifenac 100 SRT sustained release tablets are available in pack of 10 tablets.
Analgesic, Anti-inflammatory
Composition:
Emifenac 50 DT: Each Emifenac 50 DT dispersible tablet contains diclofenac 46.5mg equivalent to diclofenac sodium 50mg.
Diclofenac free acid
{2-[(2,6-dichlorophenyl)-a
Emifenac 50 DT Dispersible Tablets, specifically to disintegrate quickly in water, yielding a tasteless suspension of diclofenac free acid.
The suspension is to be taken orally.
Emifenac 100 SRT: Each Emifenac 100 SRT sustained release tablet contains diclofenac sodium 100 mg.
Indications:
Emifenac is indicated in the following conditions:
Ø Post-operative pain, inflammation, and swelling e.g. following dental or orthopedic surgery.
Ø Painful post-traumatic inflammatory states, e.g. due to sprains.
Ø Non-articular rheumatism
Ø Painful symptoms of the vertebral column.
Ø Painful and/or inflammatory conditions in gynaecology, e.g. primary dysmenorrhoea
Ø Acute attacks of gout.
Ø As an adjuvant in severe painful inflammatory infections of the ear, nose, or throat, e.g. pharyngitis, otitis. In keeping with general therapeutic principles, the underlying disease should be treated with basic therapy, as appropriate. Fever alone is not an indication.
Contraindications:
Emifenac like other non-steroidal anti-inflammatory drugs, should not be given to patients with active peptic ulcer and to patients in whom attacks of asthma, angioedema, urticaria or acute rhinitis have been precipitated by aspirin or any other drugs with prostaglandin-synthetase inhibiting activity. Emifenac should be avoided in patients with a history of acute prophyria.
Emifenac 50 DT contains phenylalanine and should not be given to phenylketonurics patients.
Dosage and Administration:
Emifenac 50 DT: Emifenac 50 DT dispersible tablets should preferably be taken before meals.
Emifenac 50 DT dispersible tablets are dropped into a glass of water and stirred to aid dispersion before swallowing. Since a portion of the active substance (diclofenac) may remain in the glass after swallowing, it is advisable to rinse the glass with a small of water and to swallow again.
Adults: The recommended initial dosage is 2-3 Emifenac 50 DT dispersible tablets.
In milder cases as well as for children over 14 years of age, 2 Emifenac 50 DT dispersible tablets daily are usually sufficient.
The daily dosage should generally be prescribed in 2-3 divided doses.
In primary dysmenorrhea the daily dosage, which should be individually adapted, is generally 1-3 Emifenac 50 DT.
Children: Because of the dosage strength, Emifenac50 DT Dispersible tablets are not recommended for use in children below 14 years of age.
Emifenac 100 SRT:
Adults: The recommended initial dosage is 1 tablet of Emifenac 100 SRT sustained release tablets.
In milder cases as well as for long-term therapy, 1 tablet of Emifenac 100 SRT is usually sufficient. Where the symptoms are most pronounced during the night or in the morning should preferably be taken in the evening. The tablets should be taken whole with liquid, preferably with meals.
Children: Because of the dosage strength, Emifenac 100 SRT sustained release tablets are not recommended for use in children below 14 years of age.
Presentation:
Emifenac 50 DT dispersible tablets are available in packs of 20 and 100 tablets.
Emifenac 100 SRT sustained release tablets are available in pack of 10 tablets.
No comments:
Post a Comment